Eva Anette Engelhardt - 25 Jul 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, President, CDG
Signature
/s/ Eva Anette Engelhardt
Issuer symbol
BIO
Transactions as of
25 Jul 2025
Net transactions value
-$23,249
Form type
4
Filing time
29 Jul 2025, 17:20:56 UTC
Previous filing
05 Mar 2025
Next filing
09 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ENGELHARDT EVA ANETTE EVP, President, CDG C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES /s/ Eva Anette Engelhardt 29 Jul 2025 0002024911

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIO.B Bio-Rad A Common Stock Options Exercise $0 +245 $0.000000 245 25 Jul 2025 Direct F1
transaction BIO BIO.B Bio-Rad A Common Stock Tax liability $23,249 -88 -36% $264.19 157 25 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -245 -25% $0.000000 738 25 Jul 2025 Bio-Rad A Common Stock 245 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.